Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Hatake K

Collect these papers and discover other ones on Labmeeting. Learn more.

Complete resection after imatinib treatment of a gastrointestinal stromal tumor of the ileum with peritoneal metastases: Report of a case.

+ cite this

+ View Abstract

Akiyoshi T, Oya M, Fujimoto Y, Kuroyanagi H, Ueno M, Yamaguchi T, Takahashi S, Hatake K, Katori M, Yamamoto N, and Muto T

Surgery today 40(3):272-6, 2010 Mar - Who cited this? | PubMed ID: 20180084 | Fulltext

Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells.

+ cite this

+ View Abstract

Hanyu A, Kojima K, Hatake K, Nomura K, Murayama H, Ishikawa Y, Miyata S, Ushijima M, Matsuura M, Ogata E, Miyazawa K, and Imamura T

Cancer science 100(11):2085-92, 2009 Nov - Who cited this? | PubMed ID: 19719773 | Fulltext

von Willebrand factor in cadaveric urine for forensic investigation.

+ cite this

+ View Abstract

Kasuda S, Kudo R, Morimura Y, Tatsumi K, Sakurai Y, Shima M, and Hatake K

Legal medicine (Tokyo, Japan) 11(5):245-7, 2009 Sep - Who cited this? | PubMed ID: 19515598 | Fulltext

Efficacy of Preventive Treatment for Delayed Emesis Induced by FOLFOX4 Chemotherapy.

+ cite this

+ View Abstract

Yokokawa T, Matsusaka S, Shouji D, Imada H, Nakamoto E, Kamisugi K, Suzuki W, Shirai T, Takahashi G, Kawakami K, Shinozaki E, Suenaga M, Mizunuma N, Hatake K, and Hama T

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 129(8):949-55, 2009 Aug - Who cited this? | PubMed ID: 19652501 | Fulltext

MICA gene polymorphism not associated with nonsyndromic cleft lip with or without cleft palate in the Japanese population?.

+ cite this

+ View Abstract

Tamaki S, Kawakami M, Yamanaka Y, Imai Y, Kawashima W, Yamamoto K, Kasuda S, Hatake K, and Kirita T

Genetic testing and molecular biomarkers 13(4):445-8, 2009 Aug - Who cited this? | PubMed ID: 19594363 | Fulltext

Familial sideroblastic anemia associated with cardiac atrial septal defect.

+ cite this

Mori M, Nakamoto S, Akifuji Y, Tanaka T, Komatsu N, Hatake K, and Ozawa K

American journal of hematology 84(7):451-2, 2009 Jul - Who cited this? | PubMed ID: 19425066 | Fulltext

An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy.

+ cite this

+ View Abstract

Mishima Y, Sugimura N, Matsumoto-Mishima Y, Terui Y, Takeuchi K, Asai S, Ennishi D, Asai H, Yokoyama M, Kojima K, and Hatake K

Clinical cancer research : an official journal of the American Association for Cancer Research 15(10):3624-32, 2009 May 15 - Who cited this? | PubMed ID: 19417028 | Fulltext

Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer.

+ cite this

+ View Abstract

Osako T, Ito Y, Ushijima M, Takahashi S, Tokudome N, Sugihara T, Iwase T, Matsuura M, and Hatake K

Cancer chemotherapy and pharmacology 63(5):865-71, 2009 Apr - Who cited this? | PubMed ID: 18670777 | Fulltext

Identification of CD20 C-Terminal Deletion Mutations Associated with Loss of CD20 Expression in Non-Hodgkin's Lymphoma.

+ cite this

+ View Abstract

Terui Y, Mishima Y, Sugimura N, Kojima K, Sakurai T, Mishima Y, Kuniyoshi R, Taniyama A, Yokoyama M, Sakajiri S, Takeuchi K, Watanabe C, Takahashi S, Ito Y, and Hatake K

Clinical cancer research : an official journal of the American Association for Cancer Research 15(7):2523-30, 2009 Apr 1 - Who cited this? | PubMed ID: 19276251 | Fulltext

[Rituximab Resistance in B-cell Lymphoma and Its Elimination.].

+ cite this

+ View Abstract

Hatake K and Terui Y

Gan to kagaku ryoho. Cancer & chemotherapy 36(4):548-51, 2009 Apr - Who cited this? | PubMed ID: 19381025 | Fulltext

Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy.

+ cite this

+ View Abstract

Ennishi D, Yokoyama M, Terui Y, Asai H, Sakajiri S, Mishima Y, Takahashi S, Komatsu H, Ikeda K, Takeuchi K, Tanimoto M, and Hatake K

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 20(3):526-33, 2009 Mar - Who cited this? | PubMed ID: 19074749 | Fulltext

Chemotherapy for small-bowel Adenocarcinoma at a single institution.

+ cite this

+ View Abstract

Suenaga M, Mizunuma N, Chin K, Matsusaka S, Shinozaki E, Oya M, Ueno M, Yamaguchi T, Muto T, Konishi F, and Hatake K

Surgery today 39(1):27-31, 2009 - Who cited this? | PubMed ID: 19132464 | Fulltext

Notice of erratum.

+ cite this

Suenaga M, Mizunuma N, Shouji D, Shinozaki E, Matsusaka S, Chin K, Oya M, Yamaguchi T, Muto T, and Hatake K

Journal of gastroenterology 44(7):801, 2009 - Who cited this? | PubMed ID: 19475332 | Fulltext

Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes.

+ cite this

+ View Abstract

Tanabe M, Ito Y, Tokudome N, Sugihara T, Miura H, Takahashi S, Seto Y, Iwase T, and Hatake K

Breast cancer (Tokyo, Japan) 16(4):301-6, 2009 - Who cited this? | PubMed ID: 19205831 | Fulltext

[Tumor lysis syndrome.].

+ cite this

+ View Abstract

Hatake K

Gan to kagaku ryoho. Cancer & chemotherapy 35(13):2334-7, 2008 Dec - Who cited this? | PubMed ID: 19098401 | Fulltext

[Relative Dose Intensity of FOLFOX4 Regimen.].

+ cite this

+ View Abstract

Shouji D, Matsusaka S, Watanabe C, Suenaga M, Shinozaki E, Matsuda M, Kuboki K, Ogura M, Ichimura T, Keisho C, Mizunuma N, and Hatake K

Gan to kagaku ryoho. Cancer & chemotherapy 35(11):1895-900, 2008 Nov - Who cited this? | PubMed ID: 19011338 | Fulltext

Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma.

+ cite this

+ View Abstract

Tamaki S, Kawakami M, Yamanaka Y, Shimomura H, Imai Y, Ishida JI, Yamamoto K, Ishitani A, Hatake K, and Kirita T

Clinical immunology (Orlando, Fla.), 2008 Oct 22 - Who cited this? | PubMed ID: 18951065 | Fulltext

Does rituximab really induce hepatitis C virus reactivation?.

+ cite this

Ennishi D, Yokoyama M, Terui Y, Takeuchi K, Ikeda K, Tanimoto M, and Hatake K

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(28):4695-6, 2008 Oct 1 - Who cited this? | PubMed ID: 18824720 | Fulltext

[A case of mediastinal cancer of unknown primary with elevation of serum concentrations of interleukin-6.].

+ cite this

+ View Abstract

Kobayashi K, Myojo T, Saotome T, Takahashi S, and Hatake K

Gan to kagaku ryoho. Cancer & chemotherapy 35(10):1799-801, 2008 Oct - Who cited this? | PubMed ID: 18931593 | Fulltext

Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors.

+ cite this

+ View Abstract

Mishima Y, Terui Y, Mishima Y, Taniyama A, Kuniyoshi R, Takizawa T, Kimura S, Ozawa K, and Hatake K

Cancer science, 2008 Sep 22 - Who cited this? | PubMed ID: 18823378 | Fulltext

Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine.

+ cite this

+ View Abstract

Ito Y, Osaki Y, Tokudome N, Sugihara T, Takahashi S, Iwase T, and Hatake K

Breast cancer (Tokyo, Japan), 2008 Sep 20 - Who cited this? | PubMed ID: 18807123 | Fulltext

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan.

+ cite this

+ View Abstract

Tokudome N, Ito Y, Hatake K, Toi M, Sano M, Iwata H, Sato Y, Saeki T, Aogi K, and Takashima S

Anti-cancer drugs 19(7):753, 2008 Aug - Who cited this? | PubMed ID: 18594220 | Fulltext

[Preparation of a Brochure for Patients Undergoing FOLFIRI Chemotherapy Based on Survey of Adverse Reactions.].

+ cite this

+ View Abstract

Kamisugi K, Matsusaka S, Imada H, Shoji D, Nakamoto E, Yokokawa T, Kawakami K, Hirata Y, Nawano K, Ogawa M, Shinozaki E, Suenaga M, Mizunuma N, Hatake K, and Hama T

Gan to kagaku ryoho. Cancer & chemotherapy 35(8):1331-5, 2008 Aug - Who cited this? | PubMed ID: 18701844 | Fulltext

CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.

+ cite this

+ View Abstract

Ennishi D, Takeuchi K, Yokoyama M, Asai H, Mishima Y, Terui Y, Takahashi S, Komatsu H, Ikeda K, Yamaguchi M, Suzuki R, Tanimoto M, and Hatake K

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 2008 Jun 23 - Who cited this? | PubMed ID: 18573805 | Fulltext

Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer.

+ cite this

+ View Abstract

Osako T, Ito Y, Takahashi S, Tokudome N, Iwase T, and Hatake K

Cancer chemotherapy and pharmacology 62(1):159-64, 2008 Jun - Who cited this? | PubMed ID: 17882419 | Fulltext

Irinotecan Plus Cisplatin for Therapy of Small-cell Carcinoma of the Esophagus: Report of 12 Cases from Single Institution Experience.

+ cite this

+ View Abstract

Chin K, Baba S, Hosaka H, Ishiyama A, Mizunuma N, Shinozaki E, Suenaga M, Kozuka T, Seto Y, Yamamoto N, and Hatake K

Japanese journal of clinical oncology 38(6):426-31, 2008 Jun - Who cited this? | PubMed ID: 18519543 | Fulltext

[Effect of ethanol on anandamide-induced sensory nerve dependent vasorelaxation (the second report)].

+ cite this

Kudo R and Hatake K

Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 43(3):204-10, 2008 Jun - Who cited this? | PubMed ID: 18646646 | Fulltext

Establishment of embryonic stem cells secreting human factor VIII for cell-based treatment of hemophilia A.

+ cite this

+ View Abstract

Kasuda S, Kubo A, Sakurai Y, Irion S, Ohashi K, Tatsumi K, Nakajima Y, Saito Y, Hatake K, Pipe SW, Shima M, and Yoshioka A

Journal of thrombosis and haemostasis : JTH, 2008 May 15 - Who cited this? | PubMed ID: 18485084 | Fulltext

[Safety and Efficacy Analysis of FOLFOX4 Regimen in Elderly Compared to Younger Colorectal Cancer Patients.].

+ cite this

+ View Abstract

Kuboki Y, Ichimura T, Ogura M, Matsuda M, Suenaga M, Shinozaki E, Matsuzaka S, Chin K, Mizunuma N, and Hatake K

Gan to kagaku ryoho. Cancer & chemotherapy 35(5):781-5, 2008 May - Who cited this? | PubMed ID: 18487913 | Fulltext

Increased incidence of interstitial pneumonia by CHOP combined with rituximab.

+ cite this

+ View Abstract

Ennishi D, Terui Y, Yokoyama M, Mishima Y, Takahashi S, Takeuchi K, Ikeda K, Tanimoto M, and Hatake K

International journal of hematology 87(4):393-7, 2008 May - Who cited this? | PubMed ID: 18409079 | Fulltext

[Retrospective Analysis of FOLFOX4 Neurotoxicity for Recovery from Advanced Colorectal Cancer.].

+ cite this

+ View Abstract

Matsuda M, Matsusaka S, Kuboki Y, Itimura T, Ogura M, Suenaga M, Syouji D, Watanabe C, Chin K, Mizunuma N, and Hatake K

Gan to kagaku ryoho. Cancer & chemotherapy 35(3):461-6, 2008 Mar - Who cited this? | PubMed ID: 18347395 | Fulltext

Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis.

+ cite this

+ View Abstract

Ide H, Hatake K, Terado Y, Tsukino H, Okegawa T, Nutahara K, Higashihara E, and Horie S

Human cell : official journal of Human Cell Research Society 21(1):1-6, 2008 Feb - Who cited this? | PubMed ID: 18190394 | Fulltext

[A Feasibility Study of Oxaliplatin (L-OHP) in Combination with Infusional 5-FU/l-LV (FOLFOX4 Regimen) for Advanced Colorectal Cancer.].

+ cite this

+ View Abstract

Suenaga M, Nishina T, Hyodo I, Munakata M, Koizumi W, Mishima H, Sato A, Mizunuma N, and Hatake K

Gan to kagaku ryoho. Cancer & chemotherapy 35(2):255-60, 2008 Feb - Who cited this? | PubMed ID: 18281761 | Fulltext

Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients.

+ cite this

+ View Abstract

Tamaki S, Sanefuzi N, Kawakami M, Aoki K, Imai Y, Yamanaka Y, Yamamoto K, Ishitani A, Hatake K, and Kirita T

Human immunology 69(2):88-93, 2008 Feb - Who cited this? | PubMed ID: 18361932 | Fulltext

Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy.

+ cite this

+ View Abstract

Ennishi D, Terui Y, Yokoyama M, Mishima Y, Takahashi S, Takeuchi K, Okamoto H, Tanimoto M, and Hatake K

American journal of hematology 83(1):59-62, 2008 Jan - Who cited this? | PubMed ID: 17712791 | Fulltext

Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan.

+ cite this

+ View Abstract

Suenaga M, Mizunuma N, Shouji D, Shinozaki E, Matsusaka S, Chin K, Oya M, Yamaguchi T, Muto T, and Hatake K

Journal of gastroenterology 43(11):842-8, 2008 - Who cited this? | PubMed ID: 19012037 | Fulltext

Management of allergic reactions to oxaliplatin in colorectal cancer patients.

+ cite this

+ View Abstract

Suenaga M, Mizunuma N, Shinozaki E, Matsusaka S, Chin K, Muto T, Konishi F, and Hatake K

The journal of supportive oncology 6(8):373-8, 2008 - Who cited this? | PubMed ID: 19149322 | Fulltext

Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphoma.

+ cite this

Ennishi D, Yokoyama M, Mishima Y, Watanabe C, Terui Y, Takahashi S, Takeuchi K, Ikeda K, Tanimoto M, and Hatake K

Leukemia & lymphoma 48(11):2241-3, 2007 Nov - Who cited this? | PubMed ID: 17990181 | Fulltext

Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients.

+ cite this

+ View Abstract

Takahashi S, Aiba K, Ito Y, Hatake K, Nakane M, Kobayashi T, Minowa S, Shibata H, Mitsuhashi J, Tsukahara S, Ishikawa E, Suzuki R, Tsuruo T, and Sugimoto Y

Cancer science 98(10):1609-16, 2007 Oct - Who cited this? | PubMed ID: 17683514 | Fulltext

Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer.

+ cite this

+ View Abstract

Mitsuhashi J, Tsukahara S, Suzuki R, Oh-hara Y, Nishi S, Hosoyama H, Katayama K, Noguchi K, Minowa S, Shibata H, Ito Y, Hatake K, Aiba K, Takahashi S, and Sugimoto Y

Human gene therapy 18(10):895-906, 2007 Oct - Who cited this? | PubMed ID: 17907967 | Fulltext

Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice.

+ cite this

+ View Abstract

Morimoto H, Takahashi M, Shiba Y, Izawa A, Ise H, Hongo M, Hatake K, Motoyoshi K, and Ikeda U

The American journal of pathology 171(3):755-66, 2007 Sep - Who cited this? | PubMed ID: 17640962 | Fulltext

Soluble HLA-G is absent from human embryo cultures: a reassessment of sHLA-G detection methods.

+ cite this

+ View Abstract

Sageshima N, Shobu T, Awai K, Hashimoto H, Yamashita M, Takeda N, Odawara Y, Nakanishi M, Hatake K, and Ishitani A

Journal of reproductive immunology 75(1):11, 2007 Aug - Who cited this? | PubMed ID: 17485119 | Fulltext

[Recent progress in rituximab therapy and its resistance--how do we overcome?].

+ cite this

+ View Abstract

Hatake K, Yokoyama M, and Terui Y

Gan to kagaku ryoho. Cancer & chemotherapy 34(8):1177-82, 2007 Aug - Who cited this? | PubMed ID: 17687198 | Fulltext

An association between the MICA-A5.1 allele and an increased susceptibility to oral squamous cell carcinoma in Japanese patients.

+ cite this

+ View Abstract

Tamaki S, Sanefuzi N, Ohgi K, Imai Y, Kawakami M, Yamamoto K, Ishitani A, Hatake K, and Kirita T

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 36(6):351-6, 2007 Jul - Who cited this? | PubMed ID: 17559497 | Fulltext

[Breast cancer and Her-2].

+ cite this

Hatake K

Nippon rinsho. Japanese journal of clinical medicine 65 Suppl 6:87-94, 2007 Jun 28 - Who cited this? | PubMed ID: 17682144 | Fulltext

Phase II study of oxaliplatin in japanese patients with metastatic colorectal cancer refractory to fluoropyrimidines.

+ cite this

+ View Abstract

Boku N, Ohtsu A, Hyodo I, Shirao K, Miyata Y, Nakagawa K, Tamura T, Hatake K, and Tanigawara Y

Japanese journal of clinical oncology 37(6):440-5, 2007 Jun - Who cited this? | PubMed ID: 17656482 | Fulltext

MEK-ERK is involved in SUMO-1 foci formation on apoptosis.

+ cite this

+ View Abstract

Utsubo-Kuniyoshi R, Terui Y, Mishima Y, Rokudai A, Mishima Y, Sugimura N, Kojima K, Sonoda Y, Kasahara T, and Hatake K

Cancer science 98(4):569-76, 2007 Apr - Who cited this? | PubMed ID: 17284251 | Fulltext

Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells.

+ cite this

+ View Abstract

Mishima Y, Terui Y, Sugimura N, Matsumoto-Mishima Y, Rokudai A, Kuniyoshi R, and Hatake K

Cancer science 98(3):364-72, 2007 Mar - Who cited this? | PubMed ID: 17270026 | Fulltext

M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system.

+ cite this

+ View Abstract

Shiba Y, Takahashi M, Yoshioka T, Yajima N, Morimoto H, Izawa A, Ise H, Hatake K, Motoyoshi K, and Ikeda U

Arteriosclerosis, thrombosis, and vascular biology 27(2):283-9, 2007 Feb - Who cited this? | PubMed ID: 17053169 | Fulltext

[Resistance to rituximab and CD20 mutation].

+ cite this

Terui Y and Hatake K

Nippon rinsho. Japanese journal of clinical medicine 65 Suppl 1:416-23, 2007 Jan 28 - Who cited this? | PubMed ID: 17474440 | Fulltext

Search Google Scholar for Hatake K

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.